Increased stiffness of the colon, spurred by chronic inflammation, may encourage the development and progression of ...
Cases of colorectal cancer in younger adults are climbing worldwide, driven by lifestyle changes and inherited genetic risks.
HealthDay News — Among adults aged 45 to 49 years who are newly eligible for colorectal cancer (CRC) screening, there are no significant differences in screening uptake in adjusted analyses, according ...
Colonoscopy conducted beyond 3 months and up to 24 months after a positive fecal immunochemical test are not linked to an ...
In addition to the IND approval, Cartography Bio also announced that CBI-1214 has been granted Fast Track designation by the FDA. This status is designed to facilitate the development and expedited ...
Colorectal cancer, or CRC, is the world's second most lethal cancer based on the number of deaths, and is the third most ...
In July, the US Food and Drug Administration (FDA) approved a new blood-based test to screen for colorectal cancer (CRC). The FDA's approval of Shield (Guardant Health) marks a notable achievement, as ...
Please provide your email address to receive an email when new articles are posted on . Despite a decline in the overall incidence of colorectal cancer in the U.S., recent population-based data from ...
Newly available noninvasive colorectal cancer tests have opened the doors to an uptick in screening, especially the first FDA-approved blood test. However, experts are unsure whether these will be as ...
Shilpa S. Murthy, an Indian American early career investigator at Yale Cancer Center has been awarded a prestigious $1.1 ...
Scientists studied factors such as viral infections, gut microbiome, and exposome that could drive cancers, as well as how to ...